Walid Abi-Saab
Chief Medical Officer · uniQure N.V.
- 2025
- Jul 2, 2026
- 6
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Walid Abi-Saab files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Matthew C. Kapusta - $12.86M in QURE purchases and sales in the last 12 months
- Jack Kaye - $2.52M in QURE purchases and sales in the last 12 months
- Robert Gut - $1.13M in QURE purchases and sales in the last 12 months
- Madhavan Balachandran - $859K in QURE purchases and sales in the last 12 months
- Kylie O'Keefe - $431K in QURE purchases and sales in the last 12 months
- Christian Klemt - $382K in QURE purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Walid Abi-Saab?
Walid Abi-Saab is a corporate insider, tracked as Chief Medical Officer of uniQure N.V. (QURE). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Walid Abi-Saab last file a Form 4?
The most recent primary Form 4 on record is dated 2 July 2026, one of 6 filings going back to 2025.
Has Walid Abi-Saab been buying or selling stock?
Recorded transactions: 0 open-market purchases and 8 open-market sales ($2.63M) across all tracked filings.
